Which has preferable earnings & valuation, EGHT or GDRX?

GoodRx has higher revenue and earnings than 8X8. GoodRx is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 8X8 $735.75M 0.35 $1.65M $0.02 91.50 GoodRx $796.85M 1.31 $30.44M $0.06 50.83

Is EGHT or GDRX more profitable?

GoodRx has a net margin of 2.61% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat GoodRx's return on equity. Company Net Margins Return on Equity Return on Assets 8X8 0.22% 25.77% 5.30% GoodRx 2.61% 7.90% 3.23%

Does the media favor EGHT or GDRX?

In the previous week, 8X8 had 2 more articles in the media than GoodRx. MarketBeat recorded 3 mentions for 8X8 and 1 mentions for GoodRx. 8X8's average media sentiment score of 0.52 beat GoodRx's score of 0.00 indicating that 8X8 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 8X8 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, EGHT or CRTO?

Criteo has higher revenue and earnings than 8X8. Criteo is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 8X8 $735.75M 0.35 $1.65M $0.02 91.50 Criteo $1.92B 0.50 $144.60M $2.14 8.92

Is EGHT or CRTO more profitable?

Criteo has a net margin of 6.06% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat Criteo's return on equity. Company Net Margins Return on Equity Return on Assets 8X8 0.22% 25.77% 5.30% Criteo 6.06% 14.98% 8.25%

Does the media prefer EGHT or CRTO?

In the previous week, 8X8 had 1 more articles in the media than Criteo. MarketBeat recorded 3 mentions for 8X8 and 2 mentions for Criteo. 8X8's average media sentiment score of 0.52 beat Criteo's score of 0.20 indicating that 8X8 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 8X8 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Criteo 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AHG or EGHT?

8X8 has a consensus target price of $2.45, suggesting a potential upside of 33.88%. Given 8X8's stronger consensus rating and higher possible upside, analysts plainly believe 8X8 is more favorable than Akso Health Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akso Health Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 8X8 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings and valuation, AHG or EGHT?

8X8 has higher revenue and earnings than Akso Health Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Akso Health Group $14.78M 56.19 -$134.98M N/A N/A 8X8 $735.75M 0.35 $1.65M $0.02 91.50

Which has better earnings and valuation, EFOR or EGHT?

ASGN has higher revenue and earnings than 8X8. ASGN is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ASGN $3.98B 0.18 $113.50M $2.26 7.82 8X8 $735.75M 0.35 $1.65M $0.02 91.50

Is EFOR or EGHT more profitable?

ASGN has a net margin of 2.46% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat ASGN's return on equity. Company Net Margins Return on Equity Return on Assets ASGN 2.46% 10.30% 4.94% 8X8 0.22% 25.77% 5.30%

Do analysts recommend RSKD or EGHT?

Riskified currently has a consensus price target of $5.96, indicating a potential upside of 16.26%. 8X8 has a consensus price target of $2.45, indicating a potential upside of 33.88%. Given 8X8's higher probable upside, analysts clearly believe 8X8 is more favorable than Riskified. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Riskified 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29 8X8 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, RSKD or EGHT?

8X8 has higher revenue and earnings than Riskified. Riskified is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Riskified $344.64M 2.20 -$27.57M -$0.11 N/A 8X8 $735.75M 0.35 $1.65M $0.02 91.50

Is RSKD or EGHT more profitable?

8X8 has a net margin of 0.22% compared to Riskified's net margin of -5.17%. 8X8's return on equity of 25.77% beat Riskified's return on equity. Company Net Margins Return on Equity Return on Assets Riskified -5.17% -3.91% -2.89% 8X8 0.22% 25.77% 5.30%

Does the media prefer RSKD or EGHT?

In the previous week, Riskified had 15 more articles in the media than 8X8. MarketBeat recorded 18 mentions for Riskified and 3 mentions for 8X8. 8X8's average media sentiment score of 0.52 beat Riskified's score of 0.15 indicating that 8X8 is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Riskified 6 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 8X8 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

8X8 (EGHT) Competitors

$1.83 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$1.86 +0.03 (+1.64%)

As of 07/2/2026 07:52 PM Eastern

Compare

EGHT vs. GDRX, CRTO, AHG, EFOR, and RSKD

Should you buy 8X8 stock or one of its competitors? MarketBeat compares 8X8 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with 8X8 include GoodRx (GDRX), Criteo (CRTO), Akso Health Group (AHG), ASGN (EFOR), and Riskified (RSKD). These companies are all part of the "business services" industry.

How does 8X8 compare to GoodRx?

8X8 (NASDAQ:EGHT) and GoodRx (NASDAQ:GDRX) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

8X8 currently has a consensus price target of $2.45, indicating a potential upside of 33.88%. GoodRx has a consensus price target of $3.81, indicating a potential upside of 25.00%. Given 8X8's higher possible upside, equities research analysts clearly believe 8X8 is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
8X8	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

GoodRx has a net margin of 2.61% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat GoodRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
8X8	0.22%	25.77%	5.30%
GoodRx	2.61%	7.90%	3.23%

GoodRx has higher revenue and earnings than 8X8. GoodRx is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
8X8	$735.75M	0.35	$1.65M	$0.02	91.50
GoodRx	$796.85M	1.31	$30.44M	$0.06	50.83

In the previous week, 8X8 had 2 more articles in the media than GoodRx. MarketBeat recorded 3 mentions for 8X8 and 1 mentions for GoodRx. 8X8's average media sentiment score of 0.52 beat GoodRx's score of 0.00 indicating that 8X8 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
8X8	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

8X8 has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market.

94.0% of 8X8 shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 2.1% of 8X8 shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

8X8 and GoodRx tied by winning 8 of the 16 factors compared between the two stocks.

How does 8X8 compare to Criteo?

8X8 (NASDAQ:EGHT) and Criteo (NASDAQ:CRTO) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

8X8 currently has a consensus price target of $2.45, suggesting a potential upside of 33.88%. Criteo has a consensus price target of $27.44, suggesting a potential upside of 43.84%. Given Criteo's stronger consensus rating and higher possible upside, analysts clearly believe Criteo is more favorable than 8X8.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
8X8	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Criteo	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44

Criteo has higher revenue and earnings than 8X8. Criteo is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
8X8	$735.75M	0.35	$1.65M	$0.02	91.50
Criteo	$1.92B	0.50	$144.60M	$2.14	8.92

94.0% of 8X8 shares are owned by institutional investors. Comparatively, 94.3% of Criteo shares are owned by institutional investors. 2.1% of 8X8 shares are owned by insiders. Comparatively, 1.5% of Criteo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Criteo has a net margin of 6.06% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat Criteo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
8X8	0.22%	25.77%	5.30%
Criteo	6.06%	14.98%	8.25%

8X8 has a beta of 1.84, indicating that its share price is 84% more volatile than the broader market. Comparatively, Criteo has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

In the previous week, 8X8 had 1 more articles in the media than Criteo. MarketBeat recorded 3 mentions for 8X8 and 2 mentions for Criteo. 8X8's average media sentiment score of 0.52 beat Criteo's score of 0.20 indicating that 8X8 is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
8X8	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Criteo	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Criteo beats 8X8 on 10 of the 16 factors compared between the two stocks.

How does 8X8 compare to Akso Health Group?

Akso Health Group (NASDAQ:AHG) and 8X8 (NASDAQ:EGHT) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

1.2% of Akso Health Group shares are held by institutional investors. Comparatively, 94.0% of 8X8 shares are held by institutional investors. 2.1% of 8X8 shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Akso Health Group has a beta of -1, suggesting that its stock price is 200% less volatile than the broader market. Comparatively, 8X8 has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

8X8 has a net margin of 0.22% compared to Akso Health Group's net margin of 0.00%. 8X8's return on equity of 25.77% beat Akso Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akso Health Group	N/A	N/A	N/A
8X8	0.22%	25.77%	5.30%

8X8 has higher revenue and earnings than Akso Health Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akso Health Group	$14.78M	56.19	-$134.98M	N/A	N/A
8X8	$735.75M	0.35	$1.65M	$0.02	91.50

In the previous week, 8X8 had 3 more articles in the media than Akso Health Group. MarketBeat recorded 3 mentions for 8X8 and 0 mentions for Akso Health Group. 8X8's average media sentiment score of 0.52 beat Akso Health Group's score of 0.00 indicating that 8X8 is being referred to more favorably in the news media.

Company	Overall Sentiment
Akso Health Group	Neutral
8X8	Positive

8X8 has a consensus target price of $2.45, suggesting a potential upside of 33.88%. Given 8X8's stronger consensus rating and higher possible upside, analysts plainly believe 8X8 is more favorable than Akso Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akso Health Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
8X8	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

8X8 beats Akso Health Group on 13 of the 14 factors compared between the two stocks.

How does 8X8 compare to ASGN?

ASGN (NYSE:EFOR) and 8X8 (NASDAQ:EGHT) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

ASGN has higher revenue and earnings than 8X8. ASGN is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASGN	$3.98B	0.18	$113.50M	$2.26	7.82
8X8	$735.75M	0.35	$1.65M	$0.02	91.50

ASGN has a net margin of 2.46% compared to 8X8's net margin of 0.22%. 8X8's return on equity of 25.77% beat ASGN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASGN	2.46%	10.30%	4.94%
8X8	0.22%	25.77%	5.30%

95.4% of ASGN shares are owned by institutional investors. Comparatively, 94.0% of 8X8 shares are owned by institutional investors. 14.3% of ASGN shares are owned by insiders. Comparatively, 2.1% of 8X8 shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ASGN presently has a consensus price target of $29.33, indicating a potential upside of 65.91%. 8X8 has a consensus price target of $2.45, indicating a potential upside of 33.88%. Given ASGN's higher possible upside, research analysts clearly believe ASGN is more favorable than 8X8.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASGN	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
8X8	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, 8X8 had 3 more articles in the media than ASGN. MarketBeat recorded 3 mentions for 8X8 and 0 mentions for ASGN. ASGN's average media sentiment score of 1.00 beat 8X8's score of 0.52 indicating that ASGN is being referred to more favorably in the media.

Company	Overall Sentiment
ASGN	Positive
8X8	Positive

ASGN has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, 8X8 has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market.

Summary

ASGN and 8X8 tied by winning 8 of the 16 factors compared between the two stocks.

How does 8X8 compare to Riskified?

Riskified (NYSE:RSKD) and 8X8 (NASDAQ:EGHT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

Riskified currently has a consensus price target of $5.96, indicating a potential upside of 16.26%. 8X8 has a consensus price target of $2.45, indicating a potential upside of 33.88%. Given 8X8's higher probable upside, analysts clearly believe 8X8 is more favorable than Riskified.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Riskified	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
8X8	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

8X8 has a net margin of 0.22% compared to Riskified's net margin of -5.17%. 8X8's return on equity of 25.77% beat Riskified's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Riskified	-5.17%	-3.91%	-2.89%
8X8	0.22%	25.77%	5.30%

Riskified has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market. Comparatively, 8X8 has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market.

In the previous week, Riskified had 15 more articles in the media than 8X8. MarketBeat recorded 18 mentions for Riskified and 3 mentions for 8X8. 8X8's average media sentiment score of 0.52 beat Riskified's score of 0.15 indicating that 8X8 is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Riskified	6 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
8X8	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

59.0% of Riskified shares are owned by institutional investors. Comparatively, 94.0% of 8X8 shares are owned by institutional investors. 17.4% of Riskified shares are owned by company insiders. Comparatively, 2.1% of 8X8 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

8X8 has higher revenue and earnings than Riskified. Riskified is trading at a lower price-to-earnings ratio than 8X8, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Riskified	$344.64M	2.20	-$27.57M	-$0.11	N/A
8X8	$735.75M	0.35	$1.65M	$0.02	91.50

Summary

8X8 beats Riskified on 11 of the 16 factors compared between the two stocks.

Get 8X8 News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EGHT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EGHT vs. The Competition

Export

Metric	8X8	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$259.46M	$17.00B	$38.45B	$12.48B
Dividend Yield	N/A	3.50%	3.17%	6.51%
P/E Ratio	91.55	67.54	78.93	24.70
Price / Sales	0.35	39.06	601.66	97.93
Price / Cash	2.49	76.19	45.62	57.09
Price / Book	1.74	6.77	9.55	6.46
Net Income	$1.65M	$385.01M	$1.07B	$337.01M
7 Day Performance	5.84%	5.00%	0.97%	1.69%
1 Month Performance	-3.17%	2.78%	0.23%	3.81%
1 Year Performance	-15.47%	-9.17%	143.56%	23.90%

8X8 Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EGHT 8X8	2.1742 of 5 stars	$1.83 flat	$2.45 +33.9%	-15.5%	$259.46M	$735.75M	91.55	1,819
GDRX GoodRx	2.9006 of 5 stars	$2.85 +1.8%	$3.81 +33.8%	-35.9%	$959.21M	$787.89M	47.51	950
CRTO Criteo	4.5304 of 5 stars	$18.60 +5.3%	$27.44 +47.6%	-23.5%	$887.32M	$1.94B	8.69	3,649	Gap Down
AHG Akso Health Group	0.452 of 5 stars	$1.45 -4.6%	N/A	+24.4%	$838.83M	$14.78M	N/A	40
EFOR ASGN	4.8834 of 5 stars	$18.72 -4.5%	$29.33 +56.7%	N/A	$805.97M	$3.98B	8.28	2,800	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EGHT) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

8X8 (EGHT) Competitors